Carl June, MD, Talks CAR T-cell Therapies at AACR Conference
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Tag: immunotherapy
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Treatment with checkpoint inhibitors is often billed as gentler than chemotherapy—and it is true that immunotherapy doesn’t come with...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
This week marks the fourth anniversary of Cancer Research Catalyst, the official blog of the American Association for Cancer...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...